-
The challenges of conducting clinical trials for neglected tropical diseases
Maria P Rebollo, Moses J Bockarie
Editorial: Clinical Investigation
-
The challenges of conducting clinical trials for neglected tropical diseases
Maria P Rebollo, Moses J Bockarie
Editorial: Clinical Investigation
-
The challenges of conducting clinical trials for neglected tropical diseases
Maria P Rebollo, Moses J Bockarie
Editorial: Clinical Investigation
-
The challenges of conducting clinical trials for neglected tropical diseases
Maria P Rebollo, Moses J Bockarie
Editorial: Clinical Investigation
-
The challenges of conducting clinical trials for neglected tropical diseases
Maria P Rebollo, Moses J Bockarie
Editorial: Clinical Investigation
-
The challenges of conducting clinical trials for neglected tropical diseases
Maria P Rebollo, Moses J Bockarie
Editorial: Clinical Investigation
-
The challenges of conducting clinical trials for neglected tropical diseases
Maria P Rebollo, Moses J Bockarie
Editorial: Clinical Investigation
-
The challenges of conducting clinical trials for neglected tropical diseases
Maria P Rebollo, Moses J Bockarie
Editorial: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Advances in the treatment of heparin-induced thrombocytopenia: latest clinical data
Gregor Hron, Andreas Greinacher
Review Article: Clinical Investigation
-
Advances in the treatment of heparin-induced thrombocytopenia: latest clinical data
Gregor Hron, Andreas Greinacher
Review Article: Clinical Investigation
-
Advances in the treatment of heparin-induced thrombocytopenia: latest clinical data
Gregor Hron, Andreas Greinacher
Review Article: Clinical Investigation
-
Advances in the treatment of heparin-induced thrombocytopenia: latest clinical data
Gregor Hron, Andreas Greinacher
Review Article: Clinical Investigation
-
Advances in the treatment of heparin-induced thrombocytopenia: latest clinical data
Gregor Hron, Andreas Greinacher
Review Article: Clinical Investigation
-
Advances in the treatment of heparin-induced thrombocytopenia: latest clinical data
Gregor Hron, Andreas Greinacher
Review Article: Clinical Investigation
-
Advances in the treatment of heparin-induced thrombocytopenia: latest clinical data
Gregor Hron, Andreas Greinacher
Review Article: Clinical Investigation
-
Advances in the treatment of heparin-induced thrombocytopenia: latest clinical data
Gregor Hron, Andreas Greinacher
Review Article: Clinical Investigation
-
Treatment of malignant pleural mesothelioma: current status and future directions
Paolo Andrea Zucali, Rita De Sanctis, Fabio De Vincenzo, Matteo Simonelli, Elena Lorenzi, Matteo Perrino, Armando Santoro
Review Article: Clinical Investigation
-
Treatment of malignant pleural mesothelioma: current status and future directions
Paolo Andrea Zucali, Rita De Sanctis, Fabio De Vincenzo, Matteo Simonelli, Elena Lorenzi, Matteo Perrino, Armando Santoro
Review Article: Clinical Investigation
-
Treatment of malignant pleural mesothelioma: current status and future directions
Paolo Andrea Zucali, Rita De Sanctis, Fabio De Vincenzo, Matteo Simonelli, Elena Lorenzi, Matteo Perrino, Armando Santoro
Review Article: Clinical Investigation
-
Treatment of malignant pleural mesothelioma: current status and future directions
Paolo Andrea Zucali, Rita De Sanctis, Fabio De Vincenzo, Matteo Simonelli, Elena Lorenzi, Matteo Perrino, Armando Santoro
Review Article: Clinical Investigation
-
Treatment of malignant pleural mesothelioma: current status and future directions
Paolo Andrea Zucali, Rita De Sanctis, Fabio De Vincenzo, Matteo Simonelli, Elena Lorenzi, Matteo Perrino, Armando Santoro
Review Article: Clinical Investigation
-
Treatment of malignant pleural mesothelioma: current status and future directions
Paolo Andrea Zucali, Rita De Sanctis, Fabio De Vincenzo, Matteo Simonelli, Elena Lorenzi, Matteo Perrino, Armando Santoro
Review Article: Clinical Investigation
-
Treatment of malignant pleural mesothelioma: current status and future directions
Paolo Andrea Zucali, Rita De Sanctis, Fabio De Vincenzo, Matteo Simonelli, Elena Lorenzi, Matteo Perrino, Armando Santoro
Review Article: Clinical Investigation
-
Treatment of malignant pleural mesothelioma: current status and future directions
Paolo Andrea Zucali, Rita De Sanctis, Fabio De Vincenzo, Matteo Simonelli, Elena Lorenzi, Matteo Perrino, Armando Santoro
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation